Skip to main content

7 Result(s)

within Bingqiong Wang Remove this filter

and

  1. No Access

    Article

    Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments

    Evidence has proven that liver fibrosis or even cirrhosis can be reversed by anti-HBV treatment. However, the difference of fibrosis regression rates in short-term and long-term antiviral therapy remain unclea...

    Shuyan Chen, Jialing Zhou, **aoning Wu, Tongtong Meng… in Hepatology International (2024)

  2. No Access

    Article

    Recompensation in treatment-naïve HBV-related decompensated cirrhosis: a 5-year multi-center observational study comparing patients with ascites and bleeding

    Recompensation between patients with ascites and bleeding was unknown in treatment-naïve HBV-related decompensated cirrhosis.

    Zhiying He, Bingqiong Wang, **aoning Wu, Zhongjie Hu… in Hepatology International (2023)

  3. No Access

    Article

    Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosis

    Antiviral therapy is effective in decreasing disease progression in HBV cirrhosis. However, the long-term effect of antiviral therapy on health-related quality of life (HRQoL) in patients with compensated HBV ...

    **aoning Wu, Jia Hong, Jialing Zhou, Yameng Sun, Lei Li… in Hepatology International (2021)

  4. No Access

    Article

    Comparison of fibrosis regression of entecavir alone or combined with pegylated interferon alpha2a in patients with chronic hepatitis B

    Antiviral treatment with necleos(t)ide analogues contributes to histological improvement and virologic response in chronic hepatitis B (CHB) patients. However, whether adding pegylated interferon alpha2a (Peg-...

    Shuyan Chen, Jialing Zhou, **aoning Wu, Tongtong Meng… in Hepatology International (2021)

  5. No Access

    Article

    Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapy

    Many models have been developed to predict liver-related events (LRE) in chronic hepatitis B, few focused on compensated HBV-induced cirrhosis. We aimed to describe the incidence of LRE and to determine indepe...

    **aoning Wu, Jialing Zhou, Yameng Sun, Huiguo Ding… in Hepatology International (2021)

  6. Article

    Open Access

    SHG/TPEF-based image technology improves liver fibrosis assessment of minimally sized needle biopsies

    Sampling size variability of liver biopsy remains a major limitation in the assessment of liver fibrosis. We aimed to evaluate the diagnostic value of a fully quantitative method (second harmonic generation/tw...

    Bingqiong Wang, Yameng Sun, Jialing Zhou, **aoning Wu… in Hepatology International (2019)

    Download PDF (3329 KB) View Article

  7. No Access

    Article

    Platelets’ increase is associated with improvement of liver fibrosis in entecavir-treated chronic hepatitis B patients with significant liver fibrosis

    Reduction of platelet count is often observed in chronic hepatitis B (CHB) patients with significant liver fibrosis. In this cohort study, we investigated whether platelets’ increase after entecavir (ETV) ther...

    Lin Wang, Bingqiong Wang, Hong You, **aoning Wu, Jialing Zhou… in Hepatology International (2018)